It is a predictable metabolic consequence of significant weight loss that applies equally to weight lost through surgery, caloric restriction, or any other GLP-1 based approach
GLP-1 drugs research: summary GLP1 drugs may move beyond diabetes and weight loss into multidisease therapies This could significantly increase the number and profile of users, including nonobese and older populations Innovations such as oral GLP1s may further accelerate uptake and accessibility For food and beverage, the shift needs to be watched closely to understand behaviour change, consumption patterns and nutritional needs GLP-1s started life as diabetes medications, then took the world by storm for treating obesity
However, there is always the possibility that hair loss may be unrelated to the medication, so its also important to speak to a healthcare provider who may recommend other testing if necessary
Common side effects that affect many people include nausea, vomiting, stomach upset, diarrhea, stomach pain, and decreased appetite
Tang L, Lee M, Kempen PJ, Yao C, Choi MR
albicans , forming a physical barrier to resist host immune factors and developing resistance to antifungal drugs (Pereira et al., 2021)